Page last updated: 2024-08-26
fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and rolipram
fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with rolipram in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnette, MS; Cabrol, D; Ferré, F; Leroy, MJ; Méhats, C; Oger, S | 1 |
Other Studies
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and rolipram
| Article | Year |
|---|---|
Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Anti-Inflammatory Agents; Bronchodilator Agents; Carboxylic Acids; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Ethers; Female; Humans; Hydrocarbons, Fluorinated; In Vitro Techniques; Lipopolysaccharides; Myometrium; Nitriles; Phosphodiesterase Inhibitors; Pregnancy; Rolipram; Tumor Necrosis Factor-alpha; Uterine Contraction | 2004 |